Sulfotransferase (ST) enzymes catalyze the sulfate conjugation of many
hormones, neurotransmitters, drugs, and xenobiotic compounds. These r
eactions result hi enhanced renal excretion of the sulfate-conjugated
reaction products, but they call also lead to the formation of ''bioac
tivated'' metabolites. ST enzymes are members of an emerging gene supe
rfamily that presently includes phenol ST (PST), hydroxysteroid ST (HS
ST), and, in plants, flavonol ST (FST) ''families,'' members of which
share at least 45% amino acid sequence identity. These families can be
further subdivided into ''subfamilies'' that are at least 60% identic
al in amino acid sequence. For example, the PST family includes both P
ST and estrogen ST (EST) subfamilies. Amino acid sequence motifs exist
within ST enzymes that are conserved throughout phylogeny. These sign
ature sequences may be involved in the binding of 3'-phosphoadenosine-
5'-phosphosulfate, the cosubstrate for the sulfonation reaction. There
are presently five known human cytosolic ST enzymes: an EST, an HSST,
and three PSTs. cDNAs and genes for all of these enzymes have been cl
oned, and chromosomal localizations have been reported for all five ge
nes. Genes for these human enzymes, as well as those of other mammalia
n cytosolic ST enzymes that have been cloned, show a high degree of st
ructural homology, with conservation of the locations of most intron/e
xon splice junctions. Human ST enzyme expression varies among individu
als. Functionally significant genetic polymorphisms for ST enzymes in
humans have been reported, and other molecular genetic mechanisms that
might be involved in the regulation of the expression of these enzyme
s are being explored. Knowledge of the molecular biology of cytosolic
ST enzymes, when placed within a context provided by decades of bioche
mical research, promises to significantly enhance our understanding of
the regulation of the sulfate conjugation of hormones, neurotransmitt
ers, and drugs.